Skip to content
Recall Observatory FDA recall evidence

Drug product

Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23 g net fill weight, Rx only, Manufactured by: Cipla Ltd., Goa, India, M.L.,, NDC 0037-0245-23

D-1075-2018

July 25, 2018

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 77850
Status
Terminated
Classification
Class II
Quantity
20,780 bottles
Official record key
drug-enforcement:D-1075-2018

Official wording

Reason: Presence of foreign substance: Potential for glass in the neck area of the glass bottles.

Code information: Lot #: GA70246, GA70254, Exp 02/2019

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    foreign substance